Esperion Therapeutics, Inc. (ESPR) Insider Trading -- Recent Executive & Director Transactions

11 insiders reported 43 Form 4 transactions for Esperion Therapeutics, Inc. (ESPR) over the past 18 months (most recent 2026-06-01). Recent activity: CARROLL J MARTIN (Director) Buy 79,873 shares, Hoffman Robert E. (Director) Buy 79,873 shares, THOMPSON JOHN CRAIG (Director) Buy 79,873 shares, Fischer Seth H. Z. (Director) Buy 79,873 shares, Shepard Jay (Director) Buy 79,873 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-06-01CARROLL J MARTINDirectorBuy79,873$0
2026-06-01Hoffman Robert E.DirectorBuy79,873$0
2026-06-01THOMPSON JOHN CRAIGDirectorBuy79,873$0
2026-06-01Fischer Seth H. Z.DirectorBuy79,873$0
2026-06-01Shepard JayDirectorBuy79,873$0
2026-03-18Looker BenjaminChief Legal OfficerSell5,708$15,412
2026-03-18Halladay BenjaminChief Financial OfficerSell6,424$17,409
2026-03-18Koenig Sheldon L.President and CEOSell25,578$69,572
2026-03-16Koenig Sheldon L.President and CEOBuy723,760$0
2026-03-16Halladay BenjaminChief Financial OfficerBuy247,430$0
2026-03-16Looker BenjaminChief Legal OfficerBuy300,840$0
2026-01-21Looker BenjaminGeneral CounselSell1,689$4,864
2025-12-18Halladay BenjaminChief Financial OfficerSell7,337$26,927
2025-12-18Looker BenjaminGeneral CounselSell6,517$23,917
2025-12-18Koenig Sheldon L.President and CEOSell48,244$177,055
2025-12-08Harlow John B. Jr.Chief Commercial OfficerBuy424,536$0
2025-10-20Looker BenjaminGeneral CounselSell1,248$3,270
2025-09-18Looker BenjaminGeneral CounselSell6,267$17,548
2025-09-18Halladay BenjaminChief Financial OfficerSell7,046$19,799
2025-09-18Koenig Sheldon L.President and CEOSell28,427$79,311
2025-07-18Looker BenjaminGeneral CounselSell1,304$1,474
2025-07-18Halladay BenjaminChief Financial OfficerSell11$12
2025-06-18Halladay BenjaminChief Financial OfficerSell7,229$8,313
2025-06-18Looker BenjaminGeneral CounselSell6,422$7,385
2025-06-18Koenig Sheldon L.President and CEOSell30,474$33,826

Source: SEC Form 4 filings · as of 2026-06-01